Jan 27, 2023 · Chimeric antigen receptor (CAR) modified T cell therapy has transformed the management of relapsed/refractory B cell malignancies.
Apr 12, 2024 · FURQAN. Video creator. Productive automotive Content! Dm For shoot services. Promoting ISB/RWP Car community @furqan._.9. STAY TUNED's ...
Abstract. Introduction: Chimeric antigen receptor (CAR)-modified T-cell therapy has revolutionized the treatment of relapsed/refractory B-cell malignancies ...